Gelonghui, May 21丨Xintiandi (301277.SZ) announced that the company (hereinafter referred to as the “Company”) recently obtained a “Pharmaceutical Production License” issued by the Henan Drug Administration and agreed to the “Pharmaceutical Production License” change application. This change mainly involves an increase in contract production; other details remain unchanged.
New entrustment items:
Trustee company: Baizheng Pharmaceutical Co., Ltd.; Commissioned variety: moxifloxacin hydrochloride tablets (specification: 0.4g); commissioned production address: No. 3888, Xuyou East Road, Dongcheng District, Xuchang City; commissioned production workshop and production line: tablet workshop, general production line. (Use only at the drug registration stage).